A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects
Clinical trial NCT04976270 · COMPLETED
Trial details
- NCT number
- NCT04976270
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2022-01-14
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.